The Motley Fool

The Fever-Tree share price has doubled. Is it time to buy the stock?

Image source: Getty Images.

Back in April, I noted that top fund manager Nick Train — often known as Britain’s Warren Buffett — had been buying posh mixers firm Fevertree Drinks (LSE: FEVR). Fever-Tree’s share price has now doubled from the lows seen in late March. Is it too late to buy the shares?

In this piece, I’m going to catch up on the latest news from the company and explain why I think this impressive business could continue to grow.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

Trading well in tough conditions

Fever-Tree’s share price fell by around 5% after last week’s half-year trading update. I think that’s a fair reaction. The company’s sales have been hit hard by pub, bar, and restaurant closures all over the world.

In the UK, these so-called on-trade sales accounted for half the group’s total sales last year. On-trade sales obviously fell to zero during lockdown. Fortunately, stay-at-home drinkers increased their purchases by 34%. This made up for much of the shortfall.

The company reported similar patterns in its European and US markets, with particularly strong growth in the US off-trade market.

However, I was a little disappointed the company didn’t give a clear indication of how its total sales changed during the first half of the year. We’ll have to wait for the half-year results in September for that information.

Can the Fever-Tree share price keep climbing?

The big question is how we should value this stock. Historically, Fever-Tree’s policy of outsourcing manufacturing has made it a very profitable business. The group’s operating profit margin was about 28% last year.

Growth has been very strong historically too. However, things are getting more difficult. Fever-Tree’s profits will obviously fall this year due to Covid-10. But profits also fell in 2019, which I view as a sign that UK growth has probably hit a natural limit.

The big question is whether the company can succeed in the USA in the way it has done in the UK. One problem is that Americans don’t drink as much G&Ts as us Britons. The other possibility is the craft gin boom has already peaked and entered a more mature phase.

Wait and see

My view is that Fever-Tree’s success in the US will depend on newer products, such as ginger ale and cola. Due to the impact of Covid-19, I think we’ll have to wait until next year before we can get an accurate idea of how well these products are selling in the US.

In the meantime, Fever-Tree’s share price of around 2,300p means the stock is trading on 45x 2021 forecast profits. A lot of success is already priced into the shares. Although I think this business probably will continue to grow, I’m not sure it justifies such a high valuation.

If I was a shareholder, I’d sit tight for now and plan to buy more during the next market correction.

A Top Share with Enormous Growth Potential

Savvy investors like you won’t want to miss out on this timely opportunity…

Here’s your chance to discover exactly what has got our Motley Fool UK analyst all fired up about this ‘pure-play’ online business (yes, despite the pandemic!).

Not only does this company enjoy a dominant market-leading position…

But its capital-light, highly scalable business model has previously helped it deliver consistently high sales, astounding near-70% margins, and rising shareholder returns … in fact, in 2019 it returned a whopping £150m+ to shareholders in dividends and buybacks!

And here’s the really exciting part…

While COVID-19 may have thrown the company a curveball, management have acted swiftly to ensure this business is as well placed as it can be to ride out the current period of uncertainty… in fact, our analyst believes it should come roaring back to life, just as soon as normal economic activity resumes.

That’s why we think now could be the perfect time for you to start building your own stake in this exceptional business – especially given the shares look to be trading on a fairly undemanding valuation for the year to March 2021.

Click here to claim your copy of this special report now — and we’ll tell you the name of this Top Growth Share… free of charge!

Roland Head has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

The renowned analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply enter your email address below to discover how you can take advantage of this.

I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement.